Practice labs, organised for your studies.

Trace IDE concepts, variables, strings, type conversion, operators, input/output, and library vocabulary using fictional pharmacy values.

Practise nested conditions, bounded loops, break/continue, functions, arguments, and return values through non-clinical BMI and workflow examples.

Build and query a learner-entered formulary while practising lists, dictionaries, indexing, slicing, NumPy arithmetic, and a safe CSV concept.

Inspect, clean, filter, select, group, and aggregate a clearly fictional ADR practice table with Pandas concepts.

Choose and interpret fictional pharmaceutical visualisations with explicit axes, title, legend, and non-clinical boundaries.

Change centre, spread, and an outlier to inspect mean, median, standard deviation, distribution shape, and careful pharmaceutical-data interpretation.

Explore a normal-distribution probability display alongside conditional-probability, Bayes, binomial, and Poisson vocabulary with visible assumptions.

Explore fictional samples, confidence intervals, hypothesis testing, Type I/II error language, p-values, and a visible rejection-region concept.

Adjust fictional dose-response patterns, inspect Pearson r and trend language, and retain the no-causality boundary.

Frame, inspect, calculate, interpret, and report a fictional comparison with Python-library concepts, visible assumptions, and limitations.

Walk through learning types, feature/label framing, splitting, training, testing, evaluation, and the overfitting boundary.

Move a fictional dose-response line, inspect coefficients, residuals, MSE, RMSE, and R², and retain the non-predictive teaching boundary.

Calculate confusion-matrix metrics and explore probability-threshold, ROC/AUC, and classification trade-offs in a simulated teaching context.

Build transparent feature splits, inspect decision paths, depth, feature-importance concepts, ensemble vocabulary, and limitations.

Explore browser-native K-means-style grouping of fictional profiles, cluster-count choice, and careful cluster interpretation.

Compare fictional enzyme activity observations, reuse and evidence limitations.

Change cycles and a fixed efficiency assumption in an idealized DNA-copy model.

Interpret a fictional monitoring trend without turning correlation into a process-control instruction.

Explore consent, representation and privacy in a fictional genomics-and-AI project.

Distinguish an illustrative immune-response observation from evidence of clinical protection.

Distinguish quality attributes, process variables and unsupported acceptance criteria.

Explore material status, traceability and escalation in a fictional warehouse.

Calculate mean, sample standard deviation and relative standard deviation for fictional readings.

Choose a traceable correction approach for a fictional quality record.

Compare a fictional reading with a reference without certifying an instrument.

Explore transparent feature structuring, classification/regression vocabulary, and natural-products model limits without making authenticity, efficacy, safety, or discovery claims.

Explore fictional molecular descriptors, structured datasets, QSAR vocabulary, and virtual-screening limits without making a drug-development prediction.

Inspect fictional formulation, excipient, solubility, release, and stability trade-offs with explicit limits of extrapolation.

Compare a fictional production observation with CQA/CPP, variability, correlation, feature-importance, and no-release-decision context.

Visualise fictional spectral/peak and noise changes while discussing multivariate analysis, regression/classification vocabulary, and analytical-decision limits.

Compare transparent fictional PK curves, coefficient/error-metric vocabulary, and nonlinear-model limits without patient-specific dosing or treatment claims.

Explore fictional safety-report fields, threshold and confusion-matrix vocabulary, bias/confounding, and the need for human pharmacovigilance review.

Inspect fictional covariate, response, and classification concepts without individual treatment recommendations or disease-risk prediction.

Assess fictional EHR/real-world-data coverage, representation, accountability, and interpretability limits without becoming clinical decision support.

Frame a fictional supervised-learning project with public-data suitability, predictors/outcomes, metrics, limitations, ethics, and a no-deployment boundary.

Explore a fictional AI lifecycle, data-quality, validation, drift, documentation, and audit checkpoint without managing data or validating a real system.

Compare fictional evidence, transparency, interpretability, accountability, and risk-framework vocabulary without issuing regulatory guidance or a compliance finding.

Explore fictional dispensing, inventory, demand, logistics, privacy, legal, and oversight concepts without operating a pharmacy workflow or forecast.

Map fictional EHR/claims/surveillance structures, privacy, representation, and population-pattern concepts without accessing records or producing a public-health forecast.

Plan a fictional translational project with validation, workflow, bias/privacy/regulatory review, and no-deployment boundary without training a model or processing real-world data.

Explore AR/VR/MR/XR, device-category, platform, and life-sciences application vocabulary without accessing hardware, platforms, or professional-use claims.

Plan a safe fictional briefing, practice, feedback, and debrief sequence for visualisation, machine-simulation, aseptic, avatar, and communication concepts without certifying competency or counselling.

Navigate a functional 2D fictional cleanroom sequence while discussing digital-twin, plant-layout, maintenance, SOP, sensor, inventory, monitoring, audit, and no-GMP-qualification boundaries.

Explore accessible fictional leaflet, tutorial, overlay, avatar, and guidance concepts without providing medication instructions, reminders, counselling, therapy, or individual care.

Frame a fictional AR/VR Pharma 4.0 project with prototype, quality/compliance, validation, accessibility, integration, review, and no-deployment boundaries.